Steven L. Hoerter
2013 - Clovis Oncology
In 2013, Steven L. Hoerter earned a total compensation of $1.3M as EVP and Chief Commercial Officer at Clovis Oncology, a 6% decrease compared to previous year.
Compensation breakdown
| Bonus | $178,475 |
|---|---|
| Option Awards | $814,746 |
| Salary | $322,917 |
| Other | $13,242 |
| Total | $1,329,380 |
Hoerter received $814.7K in option awards, accounting for 61% of the total pay in 2013.
Hoerter also received $178.5K in bonus, $322.9K in salary and $13.2K in other compensation.
Rankings
In 2013, Steven L. Hoerter's compensation ranked 5,427th out of 12,286 executives tracked by ExecPay. In other words, Hoerter earned more than 55.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,427 out of 12,286 | 56th |
Division Manufacturing | 1,886 out of 4,614 | 59th |
Major group Chemicals And Allied Products | 545 out of 1,466 | 63rd |
Industry group Drugs | 388 out of 1,160 | 67th |
Industry Pharmaceutical Preparations | 309 out of 890 | 65th |
Source: SEC filing on April 27, 2016.
Hoerter's colleagues
We found four more compensation records of executives who worked with Steven L. Hoerter at Clovis Oncology in 2013.